198 related articles for article (PubMed ID: 8726588)
41. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support.
Rabinowitz J; Petros WP; Stuart AR; Peters WP
Blood; 1993 May; 81(9):2452-9. PubMed ID: 7683220
[TBL] [Abstract][Full Text] [Related]
42. [Cytokines in the treatment of blood diseases].
Robak T
Acta Haematol Pol; 1995; 26(2 Suppl 1):72-8. PubMed ID: 7544526
[TBL] [Abstract][Full Text] [Related]
43. Granulocyte colony stimulating factor.
Nguyen YK
J Fla Med Assoc; 1994 Jul; 81(7):467-9. PubMed ID: 7525857
[TBL] [Abstract][Full Text] [Related]
44. Recombinant human erythropoietin in combination with other hematopoietic cytokines in attenuating chemotherapy-induced multilineage myelosuppression: brief communication.
Vadhan-Raj S
Semin Hematol; 1996 Jan; 33(1 Suppl 1):16-8. PubMed ID: 8714611
[No Abstract] [Full Text] [Related]
45. Diffuse plasmacytosis in a child with brainstem glioma following multiagent chemotherapy and intensive growth factor support.
Csáki C; Ferencz T; Sipos G; Kopper L; Schuler D; Borsi JD
Med Pediatr Oncol; 1996 May; 26(5):367-71. PubMed ID: 8614371
[TBL] [Abstract][Full Text] [Related]
46. Hematopoietic growth factors in cancer chemotherapy.
Morstyn G; Lieschke GJ
Cancer Chemother Biol Response Modif; 1994; 15():367-90. PubMed ID: 7540031
[No Abstract] [Full Text] [Related]
47. New developments in clinical oncology: the interdependence of bench and bedside.
Antman KH
Cancer Res; 1991 Sep; 51(18 Suppl):5060s-5064s. PubMed ID: 1679375
[TBL] [Abstract][Full Text] [Related]
48. High-dose chemotherapy: therapeutic potential in the age of growth factor support.
Ariad S; Bezwoda WR
Isr J Med Sci; 1992 Jun; 28(6):377-85. PubMed ID: 1607279
[TBL] [Abstract][Full Text] [Related]
49. Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer.
Willemse PH; Boonstra H; de Vries EG
Semin Oncol; 1994 Dec; 21(6 Suppl 16):44-50. PubMed ID: 7528450
[No Abstract] [Full Text] [Related]
50. Source of stem cell rescue: bone marrow versus peripheral blood progenitors.
Williams SF; Zimmerman T; Grad G; Mick R
J Hematother; 1993; 2(4):521-3. PubMed ID: 7522110
[TBL] [Abstract][Full Text] [Related]
51. Hematopoietic growth factors in cancer treatment.
Büchner T
Stem Cells; 1994 May; 12(3):241-52. PubMed ID: 8075591
[TBL] [Abstract][Full Text] [Related]
52. Extramedullary hematopoiesis during therapy with granulocyte colony-stimulating factor.
Redmond J; Kantor RS; Auerbach HE; Spiritos MD; Moore JT
Arch Pathol Lab Med; 1994 Oct; 118(10):1014-5. PubMed ID: 7524465
[TBL] [Abstract][Full Text] [Related]
53. The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer.
Demetri GD
Hematol Oncol Clin North Am; 1994 Feb; 8(1):233-49. PubMed ID: 8150782
[TBL] [Abstract][Full Text] [Related]
54. Hematopoietic growth factors in cancer chemotherapy.
Morstyn G; Foote M; Lieschke GJ
Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
[No Abstract] [Full Text] [Related]
55. High-dose carboplatin chemotherapy with GM-CSF and peripheral blood progenitor cell support: a model for delivering repeated cycles of dose-intensive therapy.
Shea TC; Mason JR; Storniolo AM; Bissent E; Breslin M; Mullen M; Taetle R
Cancer Treat Rev; 1993; 19 Suppl C():11-20. PubMed ID: 8106154
[TBL] [Abstract][Full Text] [Related]
56. What's new in blood progenitor cell autotransplants?
Gale RP; Reiffers J; Juttner CA
Bone Marrow Transplant; 1994 Sep; 14(3):343-6. PubMed ID: 7994255
[TBL] [Abstract][Full Text] [Related]
57. Use of cytokines during prolonged neutropenia associated with autologous bone marrow transplantation.
Peters WP
Rev Infect Dis; 1991; 13(5):993-6. PubMed ID: 1720568
[TBL] [Abstract][Full Text] [Related]
58. High-intensity chemotherapy with hematopoietic support in breast cancer.
Crown J; Vahdat L; Fennelly D; Francis P; Wasserheit C; Hudis C; Kritz A; Schneider J; Hamilton N; Gilewski T
Ann N Y Acad Sci; 1993 Nov; 698():378-88. PubMed ID: 7506505
[TBL] [Abstract][Full Text] [Related]
59. Biological and clinical aspects of hematopoietic stem cells.
Spangrude GJ
Annu Rev Med; 1994; 45():93-104. PubMed ID: 7515222
[TBL] [Abstract][Full Text] [Related]
60. The role of granulocyte colony-stimulating factor in cancer chemotherapy.
Davis I; Morstyn G
Semin Hematol; 1991 Apr; 28(2 Suppl 2):25-33. PubMed ID: 1712124
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
